Octanol
CAS 111-87-5
Octanol (CAS 111-87-5) is a Phase 2 pharmaceutical compound with 2 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Clinical Development Phase
Highest clinical development phase rendered from the matched compound identifier rows.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | Potency | 24736.444444444445 nM | 9 | - |
| - | MIC | 281.3333333333333 ug.mL-1 | 6 | - |
IUPHAR Ligand-Target Data
Curated ligand-target interaction rows with action, affinity, and literature identifiers.
| Target | Action | Affinity | PubMed |
|---|---|---|---|
| Cx23 GJE1 |
Inhibitor | - | - |
| Cx25 GJB7 |
Inhibitor | - | - |
| Cx26 GJB2 |
Inhibitor | - | - |
| Cx30 GJB6 |
Inhibitor | - | - |
| Cx30.2 GJC3 |
Inhibitor | - | - |
| Cx30.3 GJB4 |
Inhibitor | - | - |
| Cx31 GJB3 |
Inhibitor | - | - |
| Cx31.1 GJB5 |
Inhibitor | - | - |
| Cx31.9 GJD3 |
Inhibitor | - | - |
| Cx32 GJB1 |
Inhibitor | - | - |
| Cx36 GJD2 |
Inhibitor | - | - |
| Cx37 GJA4 |
Inhibitor | - | - |
| Cx40 GJA5 |
Inhibitor | - | - |
| Cx40.1 GJD4 |
Inhibitor | - | - |
| Cx43 GJA1 |
Inhibitor | - | - |
| Cx45 GJC1 |
Inhibitor | - | - |
| Cx46 GJA3 |
Inhibitor | - | - |
| Cx47 GJC2 |
Inhibitor | - | - |
| Cx50 GJA8 |
Inhibitor | - | - |
| Cx59 GJA9 |
Inhibitor | - | - |
| Cx62 GJA10 |
Inhibitor | - | - |
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| CAPRYLIC ALCOHOL | 1487826 | SU | MTHSPL |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Octanol used for in pharmaceutical contexts?
Octanol (CAS 111-87-5) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Octanol?
No adverse-event association or SIDER side-effect rows are rendered for Octanol in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Octanol also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Caprylyl Alcohol with EU status "restricted".
What clinical phase is Octanol in?
Octanol is rendered with ChEMBL max phase 2.